451 related articles for article (PubMed ID: 11511139)
1. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
Illei GG; Austin HA; Crane M; Collins L; Gourley MF; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Steinberg AD; Klippel JH; Balow JE; Boumpas DT
Ann Intern Med; 2001 Aug; 135(4):248-57. PubMed ID: 11511139
[TBL] [Abstract][Full Text] [Related]
2. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
Gourley MF; Austin HA; Scott D; Yarboro CH; Vaughan EM; Muir J; Boumpas DT; Klippel JH; Balow JE; Steinberg AD
Ann Intern Med; 1996 Oct; 125(7):549-57. PubMed ID: 8815753
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
4. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.
Boumpas DT; Austin HA; Vaughn EM; Klippel JH; Steinberg AD; Yarboro CH; Balow JE
Lancet; 1992 Sep; 340(8822):741-5. PubMed ID: 1356175
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
6. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.
Cortés-Hernández J; Ordi-Ros J; Labrador M; Segarra A; Tovar JL; Balada E; Vilardell-Tarres M
Lupus; 2003; 12(4):287-96. PubMed ID: 12729052
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
8. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.
Illei GG; Takada K; Parkin D; Austin HA; Crane M; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Pando J; Steinberg AD; Gourley MF; Klippel JH; Balow JE; Boumpas DT
Arthritis Rheum; 2002 Apr; 46(4):995-1002. PubMed ID: 11953977
[TBL] [Abstract][Full Text] [Related]
9. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
Miyamae T; Nakasima S; Imagawa T; Ito S; Katakura S; Tomono N; Mori M; Ibe M; Mitsuda T; Aihara Y; Yokota S
Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
[TBL] [Abstract][Full Text] [Related]
10. Treatment of proliferative lupus nephritis: a changing landscape.
Adu D
Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
[TBL] [Abstract][Full Text] [Related]
11. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
[TBL] [Abstract][Full Text] [Related]
12. Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine.
de Glas-Vos JW; Krediet RT; Weening JJ; Arisz L
Neth J Med; 1995 Jan; 46(1):4-14. PubMed ID: 7877712
[TBL] [Abstract][Full Text] [Related]
13. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
[TBL] [Abstract][Full Text] [Related]
14. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
15. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.
Levey AS; Lan SP; Corwin HL; Kasinath BS; Lachin J; Neilson EG; Hunsicker LG; Lewis EJ
Ann Intern Med; 1992 Jan; 116(2):114-23. PubMed ID: 1727614
[TBL] [Abstract][Full Text] [Related]
16. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
17. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
Calguneri M; Ozbalkan Z; Ozturk MA; Apras S; Ertenli AI; Kiraz S
Clin Rheumatol; 2006 Nov; 25(6):782-8. PubMed ID: 16547692
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of pulse cyclophosphamide versus pulse methylprednisolone in severe lupus nephritis.
Sesso R; Monteiro M; Sato E; Kirsztajn G; Silva L; Ajzen H
Lupus; 1994 Apr; 3(2):107-12. PubMed ID: 7920609
[TBL] [Abstract][Full Text] [Related]
20. [Appraisal of renal failure reversing therapies in lupus nephritis].
Yang X; Liang L; Zhan Z; Ye Y; Liu Y; Yu X; Chen W; Yin P
Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):113-6. PubMed ID: 11798566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
